Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data

Zhi Chen; Tao Wang; Jingli Du; Lin Sun; Guirong Wang; Ruizi Ni; Yajing An; Xueting Fan; Yufeng Li; Rui Guo; Lirong Mao; Wei Jing; Ke Shi; Jing Cheng; Qinglan Wang; Wenjuan Nie; Haican Liu; Jianqin Liang; Wenping Gong

doi:10.15212/ZOONOSES-2024-0061

Zoonoses ›› 2025, Vol. 5 ›› Issue (1) :1 DOI: 10.15212/ZOONOSES-2024-0061

REVIEW ARTICLE

research-article

Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data

Zhi Chen ¹^,^#
, Tao Wang ¹^,^#
, Jingli Du ¹^,^#
, Lin Sun ²^,^#
, Guirong Wang ³^,^#
, Ruizi Ni ¹^,⁴
, Yajing An ¹^,⁴
, Xueting Fan ⁵
, Yufeng Li ⁴^,⁶
, Rui Guo ¹^,⁴
, Lirong Mao ¹
, Wei Jing ⁷
, Ke Shi ⁸
, Jing Cheng ⁹
, Qinglan Wang ⁹^,^*
, Wenjuan Nie ⁷^,^*
, Haican Liu ⁵^,^*
, Jianqin Liang ¹^,^*
, Wenping Gong ¹^,^*

Author information +

¹ Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, the Eighth Medical Center of PLA General Hospital, Beijing 100091, China

² Laboratory of Respiratory Diseases, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Center for Children’s Health, Beijing, China

³ Department of Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing 101149, China

⁴ Graduate School, Hebei North University, Zhangjiakou 075000, Hebei, China

⁵ National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

⁶ Department of Geriatrics, the Eighth Medical Center of PLA General Hospital, Beijing 100091, China

⁷ Tuberculosis Department, Beijing Chest Hospital affiliated to Capital Medical University, Tongzhou District, Beijing 101149, China

⁸ Tuberculosis Department, The First Affiliated Hospital of Xinxiang Medical College, Weihui City, Xinxiang 453100, Henan, China

⁹ Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610213, China

*E-mail:gwp891015@whu.edu.cn (WG);

ljqbj309@163.com (JL);

liuhaican@icdc.cn (HL);

wenjuan.nie@outlook.com (WN);

wangqinglan@scu.edu.cn (QW)

Show less

History +

PDF (2946KB)

Abstract

The World Health Organization (WHO) “Global Tuberculosis Report 2024” underscores the ongoing challenges and progress in the global fight against tuberculosis (TB). Despite a slowdown in the annual increase in TB cases and a decline in TB-related deaths, the disease remains a significant public health threat with 10.8 million new cases reported in 2023. The report reveals a persistently high burden of TB, especially in low- and middle-income countries, and highlights the escalating issue of drug-resistant TB. The report also emphasizes the critical need for increased funding, improved diagnostics, and more effective TB treatment regimens. The impact of the COVID-19 pandemic on TB control has been substantial, disrupting healthcare services and exacerbating existing challenges. This paper provides an in-depth interpretation of the report, analyzes global TB trends, updates the status of drug-resistant TB, discusses the intersection between TB and HIV, and summarizes the implications of the pandemic on TB control efforts. The report concludes with a call for intensified global action, including increased investment in research and innovation, to achieve the United Nations’ Sustainable Development Goals related to TB control. The stakes are high, but with concerted efforts, the goal of ending the TB epidemic is within reach.

Keywords

Tuberculosis / Drug-resistant TB / Diagnostics and treatment / HIV co-infection / Sustainable development goals / End TB strategy

Cite this article

Download citation ▾

Zhi Chen, Tao Wang, Jingli Du, Lin Sun, Guirong Wang, Ruizi Ni, Yajing An, Xueting Fan, Yufeng Li, Rui Guo, Lirong Mao, Wei Jing, Ke Shi, Jing Cheng, Qinglan Wang, Wenjuan Nie, Haican Liu, Jianqin Liang, Wenping Gong. Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data. Zoonoses, 2025, 5 (1) : 1 DOI:10.15212/ZOONOSES-2024-0061

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	WHO. Global Tuberculosis Report 2024 . World Health Organization: Geneva; 2024: 1-68.

[2]	Pham LT, Kumar P, Dahana WD, Nguyen DH. Promoting global health transdisciplinary research for planetary health: towards achieving the 2030 Agenda for Sustainable Development. J Glob Health. 2023; 13: 03007.

[3]	United Nations . Sustainable Development Goals. Available from: https://sdgs.un.org/. Accessed Dec 11.

[4]	Ryckman T, Robsky K, Cilloni L, Zawedde-Muyanja S, Ananthakrishnan R, Kendall EA, et al. Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach. Lancet Infect Dis. 2023; 23: e59-e66.

[5]	Filardo TD, Feng PJ, Pratt RH, Price SF, Self JL. Tuberculosis - United States, 2021. MMWR Morb Mortal Wkly Rep. 2022; 71: 441-446.

[6]	United Nations . Political Declaration of the High-Level Meeting of the General Assembly on the Fight Against Tuberculosis. Available from: https://www.un.org/pga/77/wp-content/uploads/sites/105/2023/09/TB-Final-Text.pdf. Accessed Dec 9.

[7]	WHO. WHO Consolidated Guidelines on Tuberculosis: Module 3: Diagnosis - Rapid Diagnostics for Tuberculosis Detection . World Health Organization: Geneva; 2024.

[8]	Floyd K, Glaziou P, Houben R, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016-2035: definition and rationale. Int J Tuberc Lung Dis. 2018; 22: 723-730.

[9]	WHO. WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment - Drug-susceptible Tuberculosis Treatment . World Health Organization: Geneva; 2022.

[10]	WHO. WHO Consolidated Guidelines on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents . World Health Organization: Geneva; 2022.

[11]	Günther G, Ruswa N, Keller PM. Drug-resistant tuberculosis: advances in diagnosis and management. Curr Opin Pulm Med. 2022; 28: 211-217.

[12]	WHO. Key Updates to the Treatment of Drug-resistant Tuberculosis: Rapid Communication . World Health Organization: Geneva; 2024.

[13]	Koirala S, Borisov S, Danila E, Mariandyshev A, Shrestha B, Lukhele N, et al. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: results from a large global cohort. Pulmonology. 2021; 27: 403-412.

[14]	Nyang’wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, et al. Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial. Lancet Respir Med. 2024; 12: 117-128.

[15]	Zhuang L, Ye Z, Li L, Yang L, Gong W. Next-generation TB vaccines: progress, challenges, and prospects. Vaccines (Basel). 2023; 11: 1304.

[16]	Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B, et al. Final analysis of a trial of M72/AS01(E) vaccine to prevent tuberculosis. N Engl J Med. 2019; 381: 2429-2439.

[17]	UNAIDS. The Urgency of Now: AIDS at a Crossroads . UNAIDS: Geneva; 2024: 1-300.

[18]	UNAIDS. Global HIV & AIDS Statistics - Fact Sheet . UNAIDS: Geneva; 2024: 1-6.

[19]	WHO. WHO Consolidated Guidelines on Tuberculosis: Module 1: Prevention: Tuberculosis Preventive Treatment . World Health Organization: Geneva; 2020: 1-56.

[20]	Wingfield T, Karmadwala F, MacPherson P, Millington KA, Walker NF, Cuevas LE, et al. Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respir Med. 2021; 9: 556-558.

[21]	Oxlade O, Menzies D. Putting numbers on the end TB strategy-an impossible dream? Lancet Glob Health. 2016; 4: e764-e765.

[22]	Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, et al. Digital health for the end TB strategy: developing priority products and making them work. Eur Respir J. 2016; 48: 29-45.

[23]	Sakamoto H, Lee S, Ishizuka A, Hinoshita E, Hori H, Ishibashi N, Komada K, et al. Challenges and opportunities for eliminating tuberculosis - leveraging political momentum of the UN high-level meeting on tuberculosis. BMC Public Health. 2019; 19: 76.